An interventional study of Standard Post Operative Skin Care and Medipore Tape in Scarring, sponsored by NYU Langone Health. Completed at 1 site in United States. Open to participants aged 15 Years to 95 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-08-08.
Sponsored by NYU Langone Health · Not applicable, Interventional, and Treatment
This is a prospective, single-blinded, two-arm, randomized, parallel, pragmatic, effectiveness trial that will enroll patients undergoing arthroscopic anterior cruciate ligament reconstruction in order to evaluate the efficacy of using Medipore tape to improve cosmetic wound healing and scaring.
307 studies on the registry are indexed under Cicatrix; 50 are open to participants now.
This study's enrollment of 60 is above the median of 39 across 251 interventional studies indexed under Cicatrix.
Browse Cicatrix studies →NYU Langone Health is the lead sponsor of 1,391 studies on the registry; 254 are open to participants now.
Of its 227 completed or terminated interventional studies of FDA-regulated products, 191 (84%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Standard Post Operative Skin Care
Other: Standard Post Operative Skin Care
Medipore Tape will be applied to ACL reconstruction Incision
Other: Medipore Tape
Control group subjects will receive the standard post-operative skin care which are steri-strips covered with gauze, and this will be removed at the first visit. No additional skin dressings will be used in the control group.
* One layer of Medipore tape will be placed across the incision. * Patients will be instructed on how to change the tape, and will be encouraged to change the tape as often as once per week for hygiene. When patients return to the office for their regularly scheduled visit, the Medipore tape will be changed and a picture of the scar will be taken.
Change in patients' own appraisal of their scar assessed quantitatively by change in Manchester Scar Scale (MSS) Score
Time frame: 6 Months
Quantitative Assessment of Scar using Patient and Observer Scar Assessment Scale (POSAS)
Time frame: 6 Months
Dermatology Life Quality Index (DLQI)
Quantitative assessment of health-related quality of life.
Time frame: 6 Months
This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
NYU Langone Health